Share on StockTwits

Gevo (NASDAQ:GEVO) Insider Brett Lund unloaded 4,238 shares of Gevo stock on the open market in a transaction that occurred on Wednesday, July 16th. The stock was sold at an average price of $0.78, for a total value of $3,305.64. Following the completion of the sale, the insider now directly owns 110,137 shares in the company, valued at approximately $85,907. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Shares of Gevo (NASDAQ:GEVO) traded down 2.70% during mid-day trading on Thursday, hitting $0.7506. The stock had a trading volume of 113,679 shares. Gevo has a one year low of $0.73 and a one year high of $2.18. The stock has a 50-day moving average of $0.88 and a 200-day moving average of $1.12. The company’s market cap is $50.9 million.

Gevo (NASDAQ:GEVO) last released its earnings data on Wednesday, May 14th. The company reported ($0.18) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.21) by $0.03. The company had revenue of $0.90 million for the quarter, compared to the consensus estimate of $1.70 million. During the same quarter in the prior year, the company posted ($0.45) earnings per share. The company’s quarterly revenue was down 74.3% on a year-over-year basis. Analysts expect that Gevo will post $-0.67 EPS for the current fiscal year.

A number of analysts have recently weighed in on GEVO shares. Analysts at Cowen and Company cut their price target on shares of Gevo to $1.00 in a research note on Friday, May 16th. Analysts at Zacks downgraded shares of Gevo from an “outperform” rating to a “neutral” rating in a research note on Thursday, May 8th. They now have a $1.30 price target on the stock.

Gevo, Inc, is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.